Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

August 31, 2006

Conditions
CancerBreakthrough Pain
Interventions
DRUG

ACTIQ®

Trial Locations (31)

10467

Children's Hospital at Montefiore, The Bronx

13210

SUNY Upstate Medical University, Syracuse

17033

Milton S Hershey Medical Center, Hershey

19134

St. Christopher's Hospital for Children, Philadelphia

20010

Children's National Medical Center, Washington D.C.

27710

Duke University Hospital, Durham

30342

Scottish Rite Children's Medical Center, Atlanta

32207

Nemours Childrens Clinic, Jacksonville

33607

St. Joseph's Children's Hospital, Tampa

37232

Vanderbilt University Medical, Nashville

44308

Akron Children's Hospital, Akron

44501

Tod Children's Hospital, Youngstown

52242

University Hospitals of Iowa, Iowa City

53201

Childrens Hospital of Wisconsin, Milwaukee

60614

Children's Memorial Center, Chicago

Children's Memorial Hospital, Chicago

63104

Cardinal Glennon Children's Hospital, St Louis

72202

Children's Hospital of Arkansas, Little Rock

78207

Children's Cancer and Blood Disorders Center, San Antonio

78229

Methodist Hospital, San Antonio

87131

University of New Mexico, Albuquerque

90095

UCLA Pediatric Pain Program, Los Angeles

92868

Childrens Hospital of Orange, Orange

94304

Lucille Packard Childrens Hospital, Palo Alto

96826

Kapi'olani Medical Center, Honolulu

99204

Sacred Heart Medical Center, Spokane

West Virginia University, Morgantown

06106

Connecticut Childrens Medical Center, Hartford

07601

Hackensack University Medical Center, Hackensack

08901

Cancer Institute of New Jersey, New Brunswick

00912

San Jorge Childrens Medical, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00236041 - Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) | Biotech Hunter | Biotech Hunter